Johnson & Johnson is reinventing itself by renaming its pharmaceutical segment and changing its logo, the company said Sept. 14.
For more than a century, J&J's logo has been a recreation of co-founder James Wood Johnson's cursive signature on the company's first check in 1886, according to the company's website. The signature will gradually be replaced by a modern version with each letter written in one pen stroke, according to a news release.
The new logo's launch coincides with a restructuring of its Jansenn pharmaceuticals business, which will be renamed Johnson & Johnson Innovative Medicine. Its medical device and technology segment will continue to be called Johnson & Johnson MedTech.